# Corvus Pharmaceuticals, Inc. (CRVS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CRVS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -31.65M | $ -26.45M | $ 728.0K | $ 225.33M |
| 2025 | $ 0 | $ -15.65M | $ -33.76M | $ 937.0K | $ 61.21M |
| 2024 | $ 0 | $ -65.47M | $ -26.72M | $ 1.12M | $ 32.57M |
| 2023 | $ 0 | $ -29.23M | $ -25.92M | $ 1.37M | $ 38.68M |
| 2022 | $ 0 | $ -46.14M | $ -30.49M | $ 2.60M | $ 56.12M |
| 2021 | $ 0 | $ -51.40M | $ -43.65M | $ 3.65M | $ 97.16M |
| 2020 | $ 0 | $ -7.64M | $ -44.40M | $ 2.31M | $ 72.15M |
| 2019 | $ 0 | $ -60.24M | $ -48.20M | $ 3.19M | $ 71.11M |
| 2018 | $ 0 | $ -61.99M | $ -54.60M | $ 0 | $ 110.34M |
| 2017 | $ 0 | $ -74.99M | $ -62.61M | $ 0 | $ 84.84M |
| 2016 | $ 0 | $ -50.05M | $ -41.35M | $ 0 | $ 132.80M |
| 2015 | $ 0 | $ -44.00M | $ -18.36M | $ 0 | $ -31.10M |
| 2014 | $ 0 | $ -217.6K | $ -148.0K | $ 0 | $ 9.85M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 16.16 |

## Other views

- [Metrics](https://sponda.capital/en/CRVS.md)
- [Charts](https://sponda.capital/en/CRVS/charts.md)
- [Compare](https://sponda.capital/en/CRVS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.